Search results for "Highlights"
Fecal immunochemical tests vary widely in sensitivity, specificity
The test positivity rate among five commonly used fecal immunochemical tests varied from 3.9% to 16.4%, and rates of unevaluable tests ranged from 0.2% to 2.5%. The sensitivity for advanced neoplasia varied from 10.1% to 36.7%, and specificity varied from 85.5% to 96.6%.
https://gastroenterology.acponline.org/archives/2024/09/27/2.htm
27 Sep 2024
Elimination diets, PPIs most cost-effective for EoE treatment
Elimination diets were the most cost-effective strategy for treatment of eosinophilic esophagitis (EoE) over a five-year period, while proton-pump inhibitors (PPIs) were the most cost-effective first-line drugs, a recent study found.
https://gastroenterology.acponline.org/archives/2024/10/25/3.htm
25 Oct 2024
Adding factors to FIB-4 improves early identification of patients with risk of HCC
The score, which took into account age, sex, race and ethnicity, body mass index, diabetes status, smoking status, alcohol use, and Fibrosis-4 Index (FIB-4) score, found patients at risk of hepatocellular cancer (HCC) who didn't have viral hepatitis or cirrhosis.
https://gastroenterology.acponline.org/archives/2024/11/22/1.htm
22 Nov 2024
Hepatitis D co-infection linked with worse outcomes, higher mortality in hepatitis B
Patients with both hepatitis D and hepatitis B are more than twice as likely to develop hepatocellular carcinoma and decompensation and to die of liver-related causes than those with hepatitis B virus alone, according to a study of Veterans Health Administration data.
https://gastroenterology.acponline.org/archives/2024/09/27/3.htm
27 Sep 2024
Combined FIT, H. pylori testing not linked with lower gastric cancer mortality
Inviting patients to get both Helicobacter pylori stool antigen testing and a fecal immunochemical test (FIT) was associated with lower gastric cancer incidence than FIT alone after adjustment, but no change in related mortality, according to a Taiwanese trial.
https://gastroenterology.acponline.org/archives/2024/10/25/1.htm
25 Oct 2024
ACG updates guideline on H. pylori treatment
Among other recommendations, the American College of Gastroenterology (ACG) said that 14 days of bismuth quadruple therapy is the preferred regimen for treatment-naive patients with Helicobacter pylori infection when antibiotic susceptibility is unknown.
https://gastroenterology.acponline.org/archives/2024/09/27/1.htm
27 Sep 2024
FIB-4 may identify patients at risk for MASLD despite normal aminotransferase levels
More than two-thirds of primary care patients who had high or indeterminate risk for metabolic dysfunction-associated steatotic liver disease (MASLD) based on the fibrosis-4 (FIB-4) score had aminotransferase levels within normal limits.
https://gastroenterology.acponline.org/archives/2024/08/23/2.htm
23 Aug 2024
GLP-1 receptor agonists associated with retention of gastric contents during endoscopy
Patients taking glucagon-like peptide-1 (GLP-1) receptor agonists did not have any increase in upper endoscopy adverse events, a review found, leading the authors to suggest that longer fasting time before procedures would be sufficient to avoid the risks.
https://gastroenterology.acponline.org/archives/2024/08/23/3.htm
23 Aug 2024
Clinical practice update advises on management of cyclic vomiting syndrome
A basic workup for episodic vomiting should include bloodwork and urinalysis, and management of cyclic vomiting syndrome often entails multiple abortive medications, the American Gastroenterological Association said.
https://gastroenterology.acponline.org/archives/2024/07/26/3.htm
26 Jul 2024
Early vs. late paracentesis associated with better outcomes in hospitalized cirrhosis patients
Patients hospitalized with cirrhosis and ascites who received diagnostic paracentesis within 12 to 24 hours of admission had lower rates of in-hospital mortality and acute kidney injury and shorter length of stay than those who received it later, a meta-analysis found.
https://gastroenterology.acponline.org/archives/2024/07/26/2.htm
26 Jul 2024